What to look out for at SABCS 2022

Naoto T. Ueno, MD, PhD, University of Hawaii, Honolulu, HI, talks on what to look forward to at the San Antonio Breast Cancer Symposium (SABCS) 2022, including data on selective estrogen receptor degraders (SERDs), AKT inhibitors and HER2 antibody-drug conjugates (ADCs), including trastuzumab deruxtecan (T-DXd). This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.